Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Issues caused by maxillofacial tumours involve not only dealing with tumours but also repairing jaw bone defects. In traditional tumour therapy, the systemic toxicity of chemotherapeutic drugs, invasive surgical resection, intractable tumour recurrence, and metastasis are major threats to the patients’ lives in the clinic. Fortunately, biomaterial-based intervention can improve the efficiency of tumour treatment and decrease the possibility of recurrence and metastasis, suggesting new promising antitumour therapies. In addition, maxillofacial bone tissue defects caused by tumours and their treatment can negatively affect the physiological and psychological health of patients, and investment in treatment can result in a multitude of burdens to society. Biomaterials are promising options because they have good biocompatibility and bioactive properties for stimulation of bone regeneration. More interestingly, an integrated material regimen that combines tumour therapy with bone repair is a promising treatment option. Herein, we summarized traditional and biomaterial-mediated maxillofacial tumour treatments and analysed biomaterials for bone defect repair. Furthermore, we proposed a promising and superior design of dual-functional biomaterials for simultaneous tumour therapy and bone regeneration to provide a new strategy for managing maxillofacial tumours and improve the quality of life of patients in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Tissue-engineered bone regeneration
Petite, H., Viateau, V., Bensaïd, W., Meunier, A., de Pollak, C., Bourguignon, M., Oudina, K., Sedel, L., & Guillemin, G. (2000) · Nature Biotechnology · doi:10.1038/79449 · Cited by 1,475
3D-printed bioceramic scaffolds: From bone tissue engineering to tumor therapy.
Ma, H., Feng, C., Chang, J., & Wu, C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.026 · Cited by 512
The immune reaction and degradation fate of scaffold in cartilage/bone tissue engineering
Yang, D., Xiao, J., Wang, B., Li, L., Kong, X., & Liao, J. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.109927 · Cited by 192
Self-citationMesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
A Magnesium-Incorporated Nanoporous Titanium Coating for Rapid Osseointegration
Li, X., Wang, M., Zhang, W., Bai, Y., Liu, Y., Meng, J., & Zhang, L. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s255486 · Cited by 58
Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer
Guo, X., Oshima, H., Kitmura, T., Taketo, M. M., & Oshima, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800798200 · Cited by 1
Metadata
- Authors
- Tan, B., Tang, Q., Zhong, Y., Wei, Y., He, L., Wu, Y., Wu, J., & Liao, J.
- Venue
- International Journal of Oral Science
- Published
- 2021-03-16
- Volume
- 13
- Issue
- 1
- Pages
- 9-9
- ISSN
- 1674-2818 (ISSN-L)
- 2049-3169
- OpenAlex
- W3138359647
- Cited by
- 161
- References
- 7
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration. https://app.cochat.ai/papers/10.1038/s41368-021-00113-9
- The paper
- Tan, B., Tang, Q., Zhong, Y., Wei, Y., He, L., Wu, Y., Wu, J., & Liao, J. (2021). Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration. International Journal of Oral Science. https://doi.org/10.1038/s41368-021-00113-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.